# Preventing Adverse Cardiac Events in COPD

> **NCT03917914** · PHASE3 · COMPLETED · sponsor: **The George Institute** · enrollment: 280 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- Cardiovascular Diseases

## Interventions

- **DRUG:** Bisoprolol
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03917914
- **Lead sponsor:** The George Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-30
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03917914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03917914, "Preventing Adverse Cardiac Events in COPD". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT03917914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*